A new study finds that having a second child within a year of the first birth can increase a woman's risk of developing breast cancer.
The research, involving 30,000 women each of whom had produced five or more children, has shown that those with a gap of less than 12 month were 5.2 times more likely to develop the advanced ductal breast cancer than women who had a gap of three or more years.
Breast Cancer during Pregnancy
Management of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus.
Advertisement
Although it is unclear that why the risk increases, researchers believe hormones might be involved.
Alternatively, other risk factors may have influenced the results, including being overweight, and whether or not the mother chooses to breast-feed.
![Fanconi Anemia and Breast Cancer Proteins Uncovered by Replication at DNA Damage Sites]( "Fanconi Anemia and Breast Cancer Proteins Uncovered by Replication at DNA Damage Sites")
New laboratory research at The University of Texas M. D. Anderson Cancer Center shows Fanconi anemia (FA) may lead researchers toward clues in more common diseases
"Women who had their first two births close together should not be worried by these findings because the study's results are not conclusive," the Telegraph quoted Josephine Querido, senior science information officer at Cancer Research UK, as saying.
"The researchers looked at a very specific group of women - those who had a specific type of breast cancer, who had advanced tumors, who were under 50, and who had at least five children. In studies like this, dividing the group of people you're looking at into lots of smaller groups makes it likely that you'll find a positive result in one of the subgroups just by chance.
"For all women, it's important to go to the GP if they spot any unusual changes in their breast, and to go for screening when invited," Querido added.
The study appears in the British Journal of Cancer.
Source: ANI
ARU
Fanconi Anemia and Breast Cancer Proteins Uncovered by Replication at DNA Damage Sites
New laboratory research at The University of Texas M. D. Anderson Cancer Center shows Fanconi anemia (FA) may lead researchers toward clues in more common diseases
Advertisement
"Women who had their first two births close together should not be worried by these findings because the study's results are not conclusive," the Telegraph quoted Josephine Querido, senior science information officer at Cancer Research UK, as saying.
"The researchers looked at a very specific group of women - those who had a specific type of breast cancer, who had advanced tumors, who were under 50, and who had at least five children. In studies like this, dividing the group of people you're looking at into lots of smaller groups makes it likely that you'll find a positive result in one of the subgroups just by chance.
"For all women, it's important to go to the GP if they spot any unusual changes in their breast, and to go for screening when invited," Querido added.
The study appears in the British Journal of Cancer.
Source: ANI
ARU
Research: Information About the Use and Accuracy of Breast Cancer Tests is Lacking
There is little information available about the use of new testing technologies and targeted therapies in breast cancer, specifically the anti-cancer drug trastuzumab, says a new study.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Women Health News
An AI tool called Flan-T5 identified postpartum hemorrhage with 95% precision and detected 47% patients with the condition.
Active surveillance of cervical lesions was associated with higher cervical cancer risk in the long term compared to its removal.
Japan initiated the trial of selling morning-after contraceptive tablets over-the-counter in an effort to lower abortion rates and solace for rape victims.
The rising number of urinary tract infections (UTIs) among Indian women can be attributed primarily to social stigma and a lack of awareness.
Pregnant women with Sjogren's or lupus syndrome have elevated anti-Ro/SSA antibodies which are linked to fetal atrioventricular block in the heart.